Chargement en cours...
AB084. Docetaxel therapy for hormone-sensitive prostate cancer—single center result
BACKGROUND: Androgen-deprivation therapy (ADT) has been the treatment for metastatic prostate cancer for more 75 years. We assessed whether concomitant treatment with ADT added to docetaxel would result in patients newly-diagnosed metastatic hormone-sensitive prostate cancer for longer overall survi...
Enregistré dans:
| Publié dans: | Transl Androl Urol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4708668/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.s084 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|